94 related articles for article (PubMed ID: 29456647)
1. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: Guidelines by the Spanish Society of Chemotherapy.
Mensa J; Barberán J; Soriano A; Llinares P; Marco F; Cantón R; Bou G; González Del Castillo J; Maseda E; Azanza JR; Pasquau J; García-Vidal C; Reguera JM; Sousa D; Gómez J; Montejo M; Borges M; Torres A; Alvarez-Lerma F; Salavert M; Zaragoza R; Oliver A
Rev Esp Quimioter; 2018 Feb; 31(1):78-100. PubMed ID: 29480677
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
[TBL] [Abstract][Full Text] [Related]
3. Combination antimicrobial therapy in Pseudomonas aeruginosa bacteremia.
Afonso E; Conoscenti E; Blot S
Eur J Pediatr; 2020 Dec; 179(12):1997-1998. PubMed ID: 32700233
[No Abstract] [Full Text] [Related]
4. Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Dickstein Y; Lellouche J; Ben Dalak Amar M; Schwartz D; Nutman A; Daitch V; Yahav D; Leibovici L; Skiada A; Antoniadou A; Daikos GL; Andini R; Zampino R; Durante-Mangoni E; Mouton JW; Friberg LE; Dishon Benattar Y; Bitterman R; Neuberger A; Carmeli Y; Paul M;
Clin Infect Dis; 2019 Aug; 69(5):769-776. PubMed ID: 30462182
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.
Tschudin-Sutter S; Fosse N; Frei R; Widmer AF
PLoS One; 2018; 13(9):e0203295. PubMed ID: 30235247
[TBL] [Abstract][Full Text] [Related]
6. Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV.
Davar K; Clark D; Centor RM; Dominguez F; Ghanem B; Lee R; Lee TC; McDonald EG; Phillips MC; Sendi P; Spellberg B
Open Forum Infect Dis; 2023 Jan; 10(1):ofac706. PubMed ID: 36694838
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion.
Coppola N; Maraolo AE; Onorato L; Scotto R; Calò F; Atripaldi L; Borrelli A; Corcione A; De Cristofaro MG; Durante-Mangoni E; Filippelli A; Franci G; Galdo M; Guglielmi G; Pagliano P; Perrella A; Piazza O; Picardi M; Punzi R; Trama U; Gentile I
Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36140042
[TBL] [Abstract][Full Text] [Related]
8. Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens?
Oh S; Chau R; Nguyen AT; Lenhard JR
Antibiotics (Basel); 2021 May; 10(6):. PubMed ID: 34071451
[TBL] [Abstract][Full Text] [Related]
9. Periplanetasin-2 Enhances the Antibacterial Properties of Vancomycin or Chloramphenicol in
Lee H; Hwang JS; Lee DG
J Microbiol Biotechnol; 2021 Feb; 31(2):189-196. PubMed ID: 33263335
[TBL] [Abstract][Full Text] [Related]
10. The Antibacterial and Anti-biofilm Activity of Metal Complexes Incorporating 3,6,9-Trioxaundecanedioate and 1,10-Phenanthroline Ligands in Clinical Isolates of
O'Shaughnessy M; McCarron P; Viganor L; McCann M; Devereux M; Howe O
Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33027987
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobials as Single and Combination Therapy for Colistin-Resistant
Pungcharoenkijkul S; Traipattanakul J; Thunyaharn S; Santimaleeworagun W
Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32756327
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of
Shi Q; Huang C; Xiao T; Wu Z; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():68. PubMed ID: 31057792
[TBL] [Abstract][Full Text] [Related]
13. Antipseudomonal monotherapy or combination therapy for older adults with community-onset pneumonia and multidrug-resistant risk factors: a retrospective cohort study.
Obodozie-Ofoegbu OO; Teng C; Mortensen EM; Frei CR
Am J Infect Control; 2019 Sep; 47(9):1053-1058. PubMed ID: 30904374
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mono- and combination antibiotic therapy for the treatment of
Tang SY; Zhang SW; Wu JD; Wu F; Zhang J; Dong JT; Guo P; Zhang DL; Yang JT; Zhang WJ
Exp Ther Med; 2018 Mar; 15(3):2418-2428. PubMed ID: 29456647
[TBL] [Abstract][Full Text] [Related]
15. Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies.
Hu Y; Li L; Li W; Xu H; He P; Yan X; Dai H
Int J Antimicrob Agents; 2013 Dec; 42(6):492-6. PubMed ID: 24139926
[TBL] [Abstract][Full Text] [Related]
16. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis.
Safdar N; Handelsman J; Maki DG
Lancet Infect Dis; 2004 Aug; 4(8):519-27. PubMed ID: 15288826
[TBL] [Abstract][Full Text] [Related]
17. Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
Babich T; Naucler P; Valik JK; Giske CG; Benito N; Cardona R; Rivera A; Pulcini C; Abdel Fattah M; Haquin J; MacGowan A; Grier S; Gibbs J; Chazan B; Yanovskay A; Ami RB; Landes M; Nesher L; Zaidman-Shimshovitz A; McCarthy K; Paterson DL; Tacconelli E; Buhl M; Mauer S; Rodriguez-Bano J; Morales I; Oliver A; Ruiz de Gopegui E; Cano A; Machuca I; Gozalo-Marguello M; Martinez LM; Gonzalez-Barbera EM; Alfaro IG; Salavert M; Beovic B; Saje A; Mueller-Premru M; Pagani L; Vitrat V; Kofteridis D; Zacharioudaki M; Maraki S; Weissman Y; Paul M; Dickstein Y; Leibovici L; Yahav D
J Antimicrob Chemother; 2021 Jul; 76(8):2172-2181. PubMed ID: 33993273
[TBL] [Abstract][Full Text] [Related]
18. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
Wu PF; Lin YT; Wang FD; Yang TC; Fung CP
Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
